Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.64 – $10.03
24% from low
Exchange
OTC Link
ADRC
COLOPLAST AS SP/ADR
No one on the platform currently holds CLPBY.
No tracked institution reports a position in CLPBY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-22 | $0.0777 | 2026-06-01 |
| 2025-12-08 | $0.2821 | 2025-12-19 |
| 2025-05-16 | $0.0752 | 2025-05-22 |
| 2024-12-09 | $0.2391 | 2024-12-20 |
| 2024-05-17 | $0.0726 | 2024-05-28 |
| 2023-12-08 | $0.2310 | 2023-12-22 |
No one on the platform has traded CLPBY yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $29.1B | +4.9% | $2.52 | $2.46–$2.56 | 2.6× | 2 |
| 2027 | $31.2B | +7.0% | $2.70 | $2.64–$2.77 | 2.5× | 2 |
| 2028 | $33.2B | +6.6% | $2.93 | $2.89–$2.98 | 2.3× | 1 |
| 2029 | $35.6B | +7.1% | $3.27 | $3.22–$3.32 | 2.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-12 | $0.09 | $0.10 | +11.1% |
| 2026-02-06 | $0.09 | $0.10 | +11.1% |
| 2025-11-04 | $0.09 | $0.07 | -26.0% |
| 2025-08-19 | $0.02 | $0.06 | +235.2% |
| 2025-05-06 | $0.01 | $0.06 | +333.5% |
| 2025-02-04 | $0.08 | $0.07 | -12.5% |
| 2024-11-05 | $0.09 | $0.08 | -6.6% |
| 2024-08-20 | $0.09 |
| $0.08 |
| -8.7% |
| $20.0B |
| — |
| SBHMYSino Biopharmaceutical Limited | $13.01 | +0.00% | $11.6B | — |
| SDMHFSartorius Stedim Biotech S.A. | $208.48 | +3.67% | $20.3B | — |
Source: Financial Modeling Prep · peers by sector/industry